Abstract:Studies from recent years have identified a diverse population of both bacteria and fungi in the human vagina and several community signatures have emerged that are associated with susceptibility to infectious disease. A healthy vaginal bacterial microbiome is most frequently dominated by Lactobacillus species [1], yet a combination of other genera are isolated in vaginal swabs in both healthy and diseased states. The vaginal fungal mycobiome is dominated by Ascomycota, of which Candida species are the most abundant. Approximately 20% to 30% of healthy human vaginal samples contain detectable Candida at a single time point, with nearly all of those being C . albicans , and 70% of the population is expected to be vaginally colonized with Candida longitudinally [2]. Despite its prevalence in the healthy vaginal mycobiome, C . albicans is the most common causative agent of vulvovaginal candidiasis (VVC), a cause of significant morbidity in the human population. The next most common species implicated in VVC is C . glabrata , while other species including C . lusitaniae , C . tropicalis , C . parapsilosis , and C . krusei are also known to contribute to vaginal infections [3–5]. Non- albicans Candida species are typically more resistant to antifungal drugs than C . albicans [6], complicating therapeutic options and increasing treatment timelines. A disease state is often distinguished by an exaggerated inflammatory response at the vaginal mucosa [3] that leads to vulvar pruritis and erythema [7]. Polymorphic Candida species can initiate the process of filamentation, morphogenesis from single-celled yeast to multicellular hyphae, which is typically accompanied by increased tissue damage and inflammation [8]. Microbial dysbiosis has long been associated with VVC due to the observation that antibiotic usage dramatically increases the risk of onset. This notion has been challenged by several population studies [9,10]; however, other studies have found a close association between Candida and specific bacteria as well as distinct Lactobacillus species that were associated with decreased observation of fungi in samples or symptomatic VVC [11–15]. Taken together, the evidence suggests that specific bacterial species can have complex impacts on fungal burden and symptomatic infection. Shifts in the vaginal microbiome are also associated with other genital tract infections [13,16] including bacterial vaginosis (BV) and aerobic vaginitis (AV), which are characterized by the displacement of Lactobacillus species by other bacteria such as Gardnerella vaginalis , Streptococcus agalactiae , Staphylococcus aureus , Escherichia coli , and Enterococcus faecalis [17]. Both BV and AV are polymicrobial in nature and are associated with concurrent Candida carriage in many cases [18,19]. Mixed vaginitis, which can include BV or AV together with VVC, is particularly difficult to treat, and during late stages of pregnancy can lead to severe adverse maternal and neonatal outcomes [17,20]. Because it is the most abundant fungal genus in the vagina, this review will focus on the interactions between Candida species and the healthy and pathogenic bacteria found in the vaginal environment. These interactions play a significant role in maintaining homeostasis as well as impacting disease pathogenesis in the genital tract (Fig 1).

Human vaginal microbiota colonization is regulated by female sex hormones in a mouse model

Vaginal microbial dynamics and pathogen colonization in a humanized microbiota mouse model

Fertility factors affect the vaginal microbiome in women of reproductive age

Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination

Diet influences community dynamics following vaginal group B streptococcus colonization

17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice

Establishment and Validation of a Mouse Bacterial Vaginosis Model

Cervicovaginal microbiome dynamics after taking oral probiotics

Role of Progesterone in Mouse Model with Vulvovaginal Candidiasis

The Restoration of the Vaginal Microbiota after Treatment for Bacterial Vaginosis with Metronidazole or Probiotics

Molecular Analysis of the Diversity of Vaginal Microbiota Associated with Bacterial Vaginosis

Crosstalk Between Female Gonadal Hormones and Vaginal Microbiota Across Various Phases of Women’s Gynecological Lifecycle

Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip

Microbial, proteomic, and metabolomic profiling of the estrous cycle in wild house mice

Personalized Vagino-Cervical Microbiome Dynamics after Oral Probiotics

Impact of interkingdom microbial interactions in the vaginal tract

Host and Microbiome Interplay Shapes the Vaginal Microenvironment

The Vaginal Microenvironment: The Physiologic Role of Lactobacilli

Vaginal Microbiome: Environmental, Biological, and Racial Influences on Gynecological Health Across the Lifespan

Vaginal microecological characteristics of women in different physiological and pathological period

Translocation of vaginal microbiota is involved in impairment and protection of uterine health